Edinburgh, Scotland, 23 November 2023 – Green Bioactives and Azelis have announced a partnership for the promotion of Green Bioactives’ patented memory complex GBL-Memory1TM.
As part of the partnership, Azelis’ nutraceuticals team will be promoting GBL-Memory1TM in Spain and Portugal.
GBL-Memory1TM is a patented ingredient complex combining 200mg of Fructooligosaccharides with 400mg of L-theanine. In a double-blinded placebo-controlled human clinical study, it demonstrated an impressive improvement in total memory.
This memory complex can be incorporated into capsule, tablet, powder,and health drink formulations. Green Bioactives also offers a range of pack sizes for the raw material, complemented by a comprehensive private label offering of standardized and customized finished dosage forms.
Chris Meaney, Chief Business Officer at Green Bioactives said; ‘We’re delighted to be working with Azelis for the distribution of GBL-Memory1TM. Their commitment to distributing high-quality products that will deliver benefits to the market makes them an ideal partner. I’m very excited about what we can achieve together.’
Bruno Dedeurwaerdere, Market Segment Manager Nutraceuticals EMEA at Azelis adds; ‘We are thrilled about this new partnership with Green Bioactives for Spain and Portugal. The distribution of the GBL-Memory1TM complex will not only enrich Azelis' range of memory solutions, but will also enable us to meet the growing demand for high-quality products in a fast expanding market.’
Founded in 2019 as a spin-out from the University of Edinburgh, Green Bioactives are passionate about making a positive impact on the world by developing plant-based products using our innovative biomanufacturing platforms. Its mission is to improve lives with sustainable plant-derived natural products, primarily in the nutraceutical and personal care industries.GBL-Memory1 is Green Bioactives first nutraceutical product. The company recognized the need for solutions to support cognitive function for consumers looking for new ways to maintain a healthy memory. This led to their research on the combination of Fructooligosaccharides and L-theanine and its effects on human memory. The result is a patented complex that is a safe and effective solution for the nutraceutical industry.
Azelis is a leading global innovation service provider in the specialty chemical and food ingredients industry, present in 63 countries across the globe with over 3,800 employees. Our knowledgeable teams of industry, market and technical experts are each dedicated to a within Life Sciences and Industrial Chemicals. We offer a lateral value chain of complementary products to more than 59,000 customers, supported by +2,700 principal relationships, creating a turnover of €4.1 billion (2022). Azelis Group NV is listed on Euronext Brussels under ticker AZE.
Across our extensive network of more than 65 application laboratories, our award-winning staff help develop formulations and provide technical guidance throughout the customers’ product development process. We combine a global market reach with a local footprint to offer a reliable, integrated, and unique digital service to local customers and attractive -business opportunities to principals. Top industry-rated by Sustainalytics, Azelis is a leader in sustainability. We believe in building and nurturing solid, honest and transparent relationships with our people and partners.
For more information visit: www.greenbioactives.com
CONTACTS
Chris Meaney (Chief Business Officer)
info@greenbioactives.com
